Illumina (ILMN) Updates on Road Map at Investor Day StreetInsider.com (subscription) In emerging markets, Illumina will launch a human leukocyte antigen (HLA) typing product in mid-2014 for laboratories seeking next-generation sequencing on the MiSeq® platform that will be faster, less expensive, and more accurate than current ... |
